| Drug Name: | Mezlocillin (51481-65-3) |
|---|---|
| PubChem ID: | 656511 |
| SMILES: | CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C |
| InchiKey: | YPBATNHYBCGSSN-VWPFQQQWSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 539.592 |
| LogP | : | -0.2338 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 8 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 173.5 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Cefotaxime (63527-52-6) | Impaired Renal Function | Antagonistic | Not known | Focal motor status epilepticus following treatment with azlocillin and cefotaxime |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category